Melanoma‐specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non‐carriers

BACKGROUND: Inherited mutations in the CDKN2A gene are among the strongest known risk factors for cutaneous melanoma. Further, previous studies have reported inferior melanoma‐specific survival in CDKN2A mutation carriers. OBJECTIVES: Here, the melanoma‐specific survival was studied, depending on CD...

Descripción completa

Detalles Bibliográficos
Autores principales: Pissa, Maria, Lapins, Jan, Sköldmark, Christina, Helgadottir, Hildur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091727/
https://www.ncbi.nlm.nih.gov/pubmed/36156317
http://dx.doi.org/10.1111/jdv.18589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091727/
https://www.ncbi.nlm.nih.gov/pubmed/36156317
http://dx.doi.org/10.1111/jdv.18589

Ejemplares similares